Abstract
Covid-19 and Rhino-Orbital Mucormycosis – A Case Report
Highlights
There has been a rapid spread of coronavirus disease (COVID-19) globally [1]
In COVID-19 pneumonia, super-infections and coinfections are under exploration [2]
Due to the difficulty in diagnosis, mucormycosis adds onto the poor prognosis in such immune suppressed COVID-19 patients
Summary
There has been a rapid spread of coronavirus disease (COVID-19) globally [1]. In influenza, SARS, MERS, and other viral respiratory illnesses secondary infections are a well-described occurrence. In severely ill, hospitalized COVID-19 patients, secondary infections are reportedly common, encompassing between 10 and 30% of cases, fungal being 10 times more common [2]. Earlier, both Aspergillus and Candida have been reported as the main fungal pathogens for co-infection in such cases. Due to the difficulty in diagnosis, mucormycosis adds onto the poor prognosis in such immune suppressed COVID-19 patients. Detailed history was obtained from the patient He was a known case of type 2 Diabetes mellitus, on medications from past 1 year. On serial follow-up, there was gradual improvement in the eye movements of right eye, compared with the normal along with resolution of chemosis
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have